Fortress Biotech

About:

Fortress Biotech is a biopharmaceutical company that focuses on acquiring, developing, and commercializing therapeutic products.

Website: http://www.fortressbiotech.com/

Twitter/X: fortressbio

Top Investors: Hercules Capital, Oaktree Capital Management, National Securities Corporation

Description:

Fortress Biotech is a biopharmaceutical company focusing on acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. Fortress has 5 marketed products and over 25 programs in development through its majority-owned and majority-controlled partners and partners it founded and holds significant minority ownership positions. Target therapeutic areas and technologies include oncology, rare diseases, gene and cell therapy, and other areas of high unmet need.

Total Funding Amount:

$205M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

New York, New York, United States

Founded Date:

2006-01-01

Contact Email:

bd(AT)fortressbiotech.com

Founders:

Lindsay Rosenwald

Number of Employees:

101-250

Last Funding Date:

2024-09-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai